<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"><channel><title><![CDATA[Zanoprima Lifesciences 보도자료 - 뉴스와이어]]></title><link>https://www.newswire.co.kr/?md=A10&amp;act=article&amp;no=38868></link><description><![CDATA[Zanoprima Lifesciences 보도자료 - 뉴스와이어 RSS 서비스]]></description><lastBuildDate>Thu, 14 May 2026 03:06:50 +0900</lastBuildDate><copyright>Copyright (c) 2004~2026 Korea Newswire All rights reserved</copyright><image><url><![CDATA[https://file.newswire.co.kr/data/upfile/company_img/2021/10/12_3554238800_20211015104702_7859026562.jpg]]></url></image><language>ko-KR</language><item><title><![CDATA[Zanoprima Launches Commercial Production of Its High Purity Tobacco-Free Synthetic (S) Nicotine Using Revolutionary Patented New Process]]></title><link>https://www.newswire.co.kr/newsRead.php?no=932284</link><description><![CDATA[LONDON--(Business Wire/Korea Newswire)--Zanoprima Lifesciences   a UK based company, announced commercial production of its high purity synthetic (S)-Nicotine (SyNic) using a revolutionary patented process that does not involve the use of tobacco or any synthetic racemic mixture.  This is a landmark development for the trillion-dollar tobacco industry and its 1.3 billion consumers as ...]]></description><pubDate>Mon, 18 Oct 2021 09:05:00 +0900</pubDate></item><item><title><![CDATA[자노프리마, 혁신적인 특허 공정 통한 고순도 무담배 합성(S) 니코틴 상업 생산 개시]]></title><link>https://www.newswire.co.kr/newsRead.php?no=932285</link><description><![CDATA[런던, 영국--(Business Wire/뉴스와이어)--영국에 본사를 둔 자노프리마 생명과학(Zanoprima Lifesciences, 이하 자노프리마)(웹사이트:  / 링크트인: )이 담배나 합성 라세믹(racemic) 혼합물 사용이 배제된 혁신적인 특허 공정을 통한 고순도 합성 (S)-니코틴(Nicotine)(SyNic)의 상업 생산에 성공했다고 발표했다.  이는 1조달러 규모의 담배 산업과 13억 명에 달하는 담배 소비자에게는 획기적인 발전이다. 세계...]]></description><pubDate>Mon, 18 Oct 2021 09:05:00 +0900</pubDate></item></channel></rss>